BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive: Indeed, as with the imatinib-resistant cell clones, we found that the combination treatment with TKI and ABT-737 induced maximal apoptosis in imatinib-resistant primary CML cells, especially in those with the BIM deletion polymorphism (Figure 5A).